A detailed history of Hager Investment Management Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hager Investment Management Services, LLC holds 5,384 shares of VRTX stock, worth $2.38 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
5,384
Holding current value
$2.38 Million
% of portfolio
1.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$396.64 - $516.74 $2.14 Million - $2.78 Million
5,384 New
5,384 $2.17 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $113B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hager Investment Management Services, LLC Portfolio

Follow Hager Investment Management Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hager Investment Management Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hager Investment Management Services, LLC with notifications on news.